General Information of the Compound
Compound ID
CP0016777
Compound Name
2-bromo-4-(6,7-dimethoxyquinazolin-4-ylamino)phenol
    Show/Hide
Synonyms
WHI-P154
    Show/Hide
Structure
Formula
C16H14BrN3O3
Molecular Weight
376.21
Canonical SMILES
COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC
    Show/Hide
InChI
InChI=1S/C16H14BrN3O3/c1-22-14-6-10-12(7-15(14)23-2)18-8-19-16(10)20-9-3-4-13(21)11(17)5-9/h3-8,21H,1-2H3,(H,18,19,20)
    Show/Hide
InChIKey
CBIAKDAYHRWZCU-UHFFFAOYSA-N
Physicochemical Property
logP
3.8587
Rotatable Bonds
4
Heavy Atom Count
23
Polar Areas
76.5
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3795
SID: 14804325
ChEMBL ID
CHEMBL473773
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000135 A2780ADR Homo sapiens (Human)  1
1
EC50 = 3080 nM
   TI
   LI
   LO
   TS
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000036 MDCK-II Canis lupus familiaris (Dog)  1
1
EC50 = 189 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( WHI-P154 )
Drug Name WHI-P154
Indication
Diffuse large B-cell lymphoma
Investigative
Target(s)
Janus kinase 2 (JAK-2)
Inhibitor
Epidermal growth factor receptor (EGFR)
Inhibitor
Janus kinase 3 (JAK-3)
Inhibitor
Janus kinase 1 (JAK-1)
Inhibitor